Editor's Page: The Future of the Journal of Cardiac Failure: A Reinvigorated Focus on People, Partnerships and Presentation. @dranulala @robmentz https://t.co/F4f5QlHJQa

Tricuspid regurgitation in ❤️‍🩹 HFpEF isn’t benign💡 In 206 pts undergoing invasive exercise testing 🚴‍♀️ moderate–severe TR (vs absent-mild) was linked to- ⬇️ cardiac reserve - lower peak CO, higher mPAP–CO slope 3.3× higher 5-yr composite HFH or death 🔗 https://t.co/iWtQKn33IR

Lenders can more easily work with state and local agencies to find grants and programs that may help borrowers afford a home thanks to our streamlined resources. Learn how.

📝 Don’t miss the accompanying editorial! It dives deeper into this #HeartFailure study — exploring: 📍Diverse etiologies of high-output HF (HOHF) 💭How these findings challenge conventional wisdom 🔍Practical implications for clinical care 🔗 https://t.co/I9y0jicXKQ

🚨High-output heart failure (HOHF): when more isn’t better! 🤔Which hemodynamic parameter best predicts outcomes in HOHF? 📉PCWP, PAPi & PAP→not independently linked to mortality 💡Elevated cardiac index (CI) = strongest predictor of all-cause mortality 🔗 https://t.co/egT84l9Ncq

🔎 Can provocative testing during RHC unmask HFpEF? PAWP with🦵passive leg raise & 🚴‍♀️low-workload exercise help narrow the diagnostic gray zone. 🧠 Great for ruling in HFpEF — less reliable for ruling it out! 🔗 https://t.co/RuQOdn2jMR #Hemodynamics #HFpEF

Read more here: https://t.co/pk0oYXV6cy @MollySilkowski @MEspositoMD

🚨Can the Assisted Aortic Pulsatility Index (API) help guide weaning from IABP? 📊Assisted API = (Assisted SBP – Assisted DBP) / PCWP 💡This original research in our Hemodynamics Focus Issue shows that assisted API is a sensitive & specific predictor of successful device weaning.

Pacemakers in HFpEF = more than a marker⚡ HFpEF+PM pts had... Worse biatrial/ventricular function ⬇️exercise reserve ⬆️HFH/death (HR ~ 1.8 vs no PM) Mechanistic insights demonstrating that pacing may compound mechanical & chronotropic limitations. 🔗 https://t.co/PGiatXpNut

#Hemodynmaics #ExerciseTesting #CPET @VerwerftJan @FH_Verbrugge

New science 🚨 Simple 1-point mPAP/CO ratios during 🚴‍♂️CPET w/echo predict outcomes in unexplained dyspnea - matching complex slope methods but with 🔥 higher reproducibility! Practical tool for assessing #ExercisePH 🫁🫀 🔗 https://t.co/RBb8aQo90G

Final Call for Submissions! 🚨 Focus Issue: Infiltrative & Inflammatory Cardiomyopathies Your research belongs here. Submit to #JCF’s upcoming Focus Issue. Learn More: https://t.co/pIFbsqRLhp 📆Deadline: Dec. 8, 2025 #CardioTwitter #CallForPapers #Hemodynamics #AcademicMed

Submit Now - Deadline is Approaching! Focus Issue: Infiltrative & Inflammatory Cardiomyopathies Share your insights. Elevate the field. Publish early 2026 with #JCF. See Topics: https://t.co/pIFbsqRdrR 📆Deadline: Dec. 8, 2025 #CardioTwitter #HeartFailure #CardiologyResearch

The must-read editorial that accompanies this research breaks down the article, and also asks an unresolved question⁉️: should an ICD be implanted *after* LVAD placement in patients who do not already have one?🤔 🔗 https://t.co/3XgnbXcDIi

Benefits of ICDs & CRT-Ds⚡️ in HM3 LVAD pts is uncertain. This analysis of the MOMENTUM-3 trial showed that the presence of these devices was not associated with ⬆️survival, quality of life, or functional capacity in HM3 LVAD pts. 🔗 https://t.co/16LwyClnph

Deadline Approaching! Focus Issue: Infiltrative & Inflammatory Cardiomyopathies Your work can drive discovery. Submit to #JCF’s 2026 Focus Issue. Explore Topics: https://t.co/pIFbsqRdrR 📆Deadline: Dec. 8, 2025 #CardioTwitter #HeartFailure #CardiologyResearch

Accompanying this research is an 🔥 editorial by @TomCascinoMD & @GBarnesMD that analyzes the article & advocates for a systematic evaluation of disparities to enhance care in HF. 🔗 https://t.co/0do7N5BHb8

Effective communication📢 is key in 🫀 Tx! This article analyzed outcomes of non-native English-speaking (NNES) recipients vs native English-speaking (NES) recipients and found that there were no diff in 1y & 5y post-HT outcomes📈 between the 2 groups. 🔗 https://t.co/b5TuPTYO4k

🖥️AI can play a key role in prevention, early detection & treatment of HF, driven by advancements like multimodal LLMs. But challenges like data privacy, system integration, clinician trust & fairness/bias need to be addressed. Learn more in this Review: https://t.co/cBUhh1cGap

Also, don’t miss the accompanying 📜 editorial comment which highlights the urgent need for strategies to promote equitable and risk-aligned HF care within the VA system & across the broader health care landscape. 🏥 🔗 https://t.co/x6A2ARYCUY

In this VA study, the rates of early 🫀follow-up after HFH were low overall & were only modestly associated w/mortality risk at discharge. Increasing the visit rate after HFH should be evaluated as a mechanism to improve outcomes after HFH! 🔗 https://t.co/WN1zwIny5j 🧵

Check out the accompanying editorial - Equip. Engage. Empower. It talks about how to better center LVAD patient values in care conversations. ✔️From pre-implantation to long-term support, values-based tools are essential. 🖇️ https://t.co/WKbqi6OG3j